Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-01 Sale |
2024-04-03 4:05 pm |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $13.59 | $135,939 | 80,000 (Direct) |
View |
| 2024-01-26 Sale |
2024-01-30 5:03 pm |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $11.14 | $111,364 | 189,200 (Direct) |
View |
| 2021-06-28 Purchase |
2021-06-29 4:16 pm |
Fulcrum Therapeutics Inc. | FULC | Morabito Christopher Chief Medical Officer |
1,100 | $9.16 | $10,076 | 1,100 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-21 Option Award |
2025-03-25 4:05 pm |
N/A 2035-03-20 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
262,500 | $0 | 262,500 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 4:05 pm |
N/A 2032-07-31 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $0 | 80,000 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 4:05 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $3.87 | 80,000 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-12 4:06 pm |
N/A 2034-02-07 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-30 5:03 pm |
N/A 2032-07-31 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $0 | 189,200 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-30 5:03 pm |
N/A N/A |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
10,000 | $3.87 | 189,200 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 08:04 am |
N/A 2033-01-31 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-02 08:51 am |
N/A 2032-07-31 |
Astria Therapeutics Inc. | ATXS | Morabito Christopher Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Fulcrum Therapeutics Inc. | FULC | Morabito Christopher Chief Medical Officer |
59,744 | $0 | 59,744 (Direct) |
View |
| 2021-05-10 Option Award |
2021-05-12 4:30 pm |
N/A 2031-05-09 |
Fulcrum Therapeutics Inc. | FULC | Morabito Christopher Chief Medical Officer |
163,000 | $0 | 163,000 (Direct) |
View |
Ownership |
2021-05-12 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Morabito Christopher Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |